Dr Greg Arndt joined Children’s Cancer Institute Australia in 2008 to establish the ACRF Drug Discovery Centre for Childhood Cancer.

He received his PhD from the University of Saskatchewan, Canada, in 1993 and worked as a postdoctoral fellow at the R.W. Johnson Pharmaceutical Research Institute. Prior to joining CCIA, Dr Arndt was Research Director and Project Leader with Johnson & Johnson Research Pty Ltd, where he spent 15 years in increasingly senior roles focusing on cell-based screening as a tool for developing novel therapeutics.

Upon joining the DDC, Dr Arndt spent six months training at the Walter & Eliza Hall Medical Research Institute (WEHI) to gain further experience with high throughput chemical screening in an academic setting.

In addition to industry experience, Dr Arndt has also had significant academic involvement, being an Adjunct Senior Lecturer (2005-2007) and Senior Visiting Fellow (2007-2013) in the School of Biotechnology and Biomolecular Science, UNSW. In this context, he has successfully trained several Honours and PhD students and published numerous manuscripts in high-quality journals including Journal of Biological Chemistry, Current Opinions in Microbiology and Nucleic Acids Research. His research has also led to the submission of several international patent applications.